Rankings / Mood, Anxiety & Stress

Electroconvulsive therapy (ECT)

Mood, Anxiety & Stress · Procedural neuromodulation (induced seizure)

Tier B

Reviewed by Read Off Label · Last reviewed · How we grade

neuromodulationtrdcatatoniabipolarproceduralprescription
6.8 / 10
Tier B
Ev 8 Bn 8 Sf 5

Bottom line

Read Off Label grades Electroconvulsive therapy (ECT) as B (6.8/10) based on strong evidence, high benefit magnitude, and a med-risk safety profile.

The single most effective treatment for severe and treatment-resistant depression — and one of the most stigmatized.

Studied, labeled, or reported-use context: Acute course typically 2-3 sessions/week x 6-12 sessions; maintenance 1-4 sessions/month for relapse… — In-hospital procedure under general anesthesia with informed consent; covered by most insurers for TRD/catatonia/psychotic depression; not individualized guidance.

What the evidence says

The single most effective treatment for severe and treatment-resistant depression — and one of the most stigmatized. Modern ECT (general anesthesia + muscle relaxants + ultrabrief-pulse + right-unilateral electrode placement) bears little resemblance to the un-anesthetized procedure depicted in "One Flew Over the Cuckoo's Nest" (1975). ELEKT-D (Anand 2023 NEJM n=403) showed IV ketamine NONINFERIOR to ECT in non-psychotic TRD with fewer cognitive side effects — shifted first-line TRD practice toward ketamine when available; Clinical guidelines and practice use ECT for psychotic depression, severe suicidality, catatonia, mania, pregnancy, and medically complex older adults. 2024 ELEKT-D inpatient subgroup analysis: severe/inpatient cases get more early benefit from ECT; outpatient/moderate cases match on ketamine. 2025 ELEKT-D cognitive secondary analysis (Lancet Psych) confirmed ECT had significantly worse scores across all cognitive tasks at end of treatment; gap narrowed at 6 months. 2024 autobiographical-memory MA (n=432 + 173 controls) found ECT patients had larger autobiographical memory loss immediately post-treatment vs controls. 2024 international patient survey (Int J Mental Health) found 71% of recipients reported anterograde amnesia and 80% retrograde amnesia lasting >3 years — though objective neuropsych testing typically shows less impairment than patient-reported. The patient-experience gap is the main reason ECT remains controversial despite efficacy. Listed in this database because biohacker readers need a calibrated reference point: ECT is the high-water mark of efficacy in mental health against which newer interventions (ketamine; zuranolone; KarXT; psilocybin; TMS) are benchmarked. Not a biohacking intervention — included for completeness of the mental health landscape.

Mechanism

Brief electrical stimulus (0.5-8 sec) delivered under general anesthesia and neuromuscular blockade induces a controlled generalized tonic-clonic seizure (~30-90 sec); proposed antidepressant mechanisms include massive monoamine release; HPA-axis normalization; BDNF/neuroplasticity upregulation; anti-inflammatory effects; hippocampal neurogenesis; and seizure-induced default-mode-network reconfiguration; modern technique uses brief or ultrabrief pulse plus right-unilateral electrode placement to minimize cognitive side effects

Studied, labeled, or reported dose & route

Acute course typically 2-3 sessions/week x 6-12 sessions; maintenance 1-4 sessions/month for relapse prevention; ultrabrief-pulse right-unilateral minimizes cognitive side effects vs. bitemporal/brief-pulse

This records doses and routes described in studies, approved labeling, clinical practice, or documented use. It is not individualized guidance and does not establish safety; context changes with indication, formulation, health history, monitoring, and other medicines.

Citations

A link means the source informed this entry; it does not mean every claim on the page comes from that source. If a citation looks wrong or you want a claim re-checked, send a correction.

Common questions

What does the evidence show about Electroconvulsive therapy (ECT)'s effects?
Read Off Label rates the evidence for Electroconvulsive therapy (ECT) as Strong and the benefit magnitude as high, producing an overall grade of B (6.8/10). The single most effective treatment for severe and treatment-resistant depression — and one of the most stigmatized.
What safety findings are reported for Electroconvulsive therapy (ECT)?
Electroconvulsive therapy (ECT) has a med risk profile in the database. Med (cognitive side effects are the central decision input — acute confusion and anterograde amnesia common; retrograde autobiographical-memory loss documented in 2024 MA; 71-80% of patients self-report subjective long-term memory deficits in 2024 survey but objective neuropsych testing shows less impairment; mortality ~1 in 10,000 to 50,000 — comparable to general anesthesia) Legal status: In-hospital procedure under general anesthesia with informed consent; covered by most insurers for TRD/catatonia/psychotic depression.
What doses or routes are reported for Electroconvulsive therapy (ECT)?
Acute course typically 2-3 sessions/week x 6-12 sessions; maintenance 1-4 sessions/month for relapse prevention; ultrabrief-pulse right-unilateral minimizes cognitive side effects vs. bitemporal/brief-pulse This is context from studies, approved labeling, clinical practice, or documented use; it is not individualized guidance and does not establish safety.
How does Electroconvulsive therapy (ECT) work?
Brief electrical stimulus (0.5-8 sec) delivered under general anesthesia and neuromuscular blockade induces a controlled generalized tonic-clonic seizure (~30-90 sec); proposed antidepressant mechanisms include massive monoamine release; HPA-axis normalization; BDNF/neuroplasticity upregulation; anti-inflammatory effects; hippocampal neurogenesis; and seizure-induced default-mode-network reconfiguration; modern technique uses brief or ultrabrief pulse plus right-unilateral electrode placement to minimize cognitive side effects

This is an independent synthesis of published research by a non-clinician. Scores are opinions supported by citations, not prescriptions. See the full disclaimer and methodology for how this score was produced and what it does and doesn't mean.